| 12410116 |
Compounds and use thereof in methods of treatment |
Mathias FRANCOIS, Johannes Zuegg, Jeroen OVERMAN, Sreeman Kumar MAMIDYALA, Angela Aguslyarti SALIM +3 more |
2025-09-09 |
| 12350349 |
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors |
John DiPersio |
2025-07-08 |
| 12304941 |
Suppression of cytokine release syndrome in chimeric antigen receptor cell therapy |
John DiPersio, Alun Carter |
2025-05-20 |
| 12221434 |
Sulfonamide carboxamide compounds |
David Miller, Angus Murray MacLeod, Stephen Thom, Jonathan Shannon, Jokin Carrillo Arregui |
2025-02-11 |
| 12187702 |
Sulfonamideurea compounds |
David Miller, Angus Murray MacLeod, Jonathan Shannon, Jokin CARRILLO ARREGUI, Jimmy Van Wiltenburg +1 more |
2025-01-07 |
| 12168653 |
Sulfonamide derivates as NLRP3 inhibitors |
David Miller, Jimmy Van Wiltenburg, Jonathan Shannon, Stephen St-Gallay |
2024-12-17 |
| 12030879 |
Sulfonyl acetamides as NLRP3 inhibitors |
David Miller, Jimmy Van Wiltenburg, Johannes Wilhem Georg Meissner, Jochem Theodoor Van Herpt, Zhou Min Lion +2 more |
2024-07-09 |
| 12012392 |
Sulfonamide carboxamide compounds |
David Miller, Angus Murray MacLeod, Stephen Thom, Stephen St-Gallay, Jonathan Shannon +1 more |
2024-06-18 |
| 11981667 |
Sulfonamide carboxamide compounds |
David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen Thom, Stephen St-Gallay +1 more |
2024-05-14 |
| 11926600 |
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
David Miller, Angus Murray MacLeod, Stephen Thom, Stephen St-Gallay, Jonathan Shannon |
2024-03-12 |
| 11905252 |
Compounds |
David Miller, Angus Murray MacLeod, Jonathan Shannon |
2024-02-20 |
| 11884645 |
Sulfonyl acetamides as NLRP3 inhibitors |
David Miller, Jimmy Van Wiltenburg |
2024-01-30 |
| 11858922 |
Sulfonylureas and related compounds and use of same |
Luke O'Neill, Rebecca Coll, Avril Robertson, Kate Schroder, Angus Murray MacLeod +1 more |
2024-01-02 |
| 11840543 |
Compounds and uses |
Luke O'Neill, Rebecca Coll, Avril Robertson, Kate Schroder, Angus Murray MacLeod +1 more |
2023-12-12 |
| 11834433 |
Compounds |
David Miller, Jimmy Van Wiltenburg |
2023-12-05 |
| 11613542 |
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
David Miller, Angus Murray MacLeod, Stephen Thom, Stephen St-Gallay, Jonathan Shannon +4 more |
2023-03-28 |
| 11542255 |
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
David Miller, Angus Murray MacLeod, Stephen Thom, Stephen St-Gallay, Jonathan Shannon +3 more |
2023-01-03 |
| 11530200 |
Compounds |
David Miller, Jimmy Van Wiltenburg |
2022-12-20 |
| 11465992 |
Sulfonamide carboxamide compounds |
David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen Thom, Stephen St-Gallay +1 more |
2022-10-11 |
| 11434190 |
Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases |
Mathias FRANCOIS, Johannes Zuegg, Jeroen OVERMAN, Sreeman Kumar MAMIDYALA, Angela Aguslyarti SALIM +3 more |
2022-09-06 |
| 11370776 |
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen Thom, Stephen St-Gallay +1 more |
2022-06-28 |
| 11279733 |
Peptide antibiotics |
Mark Arnold Thomas Blaskovich, Alejandra Gallardo-Godoy, Karl Hansford, Alysha Elliott, Craig Muldoon +1 more |
2022-03-22 |
| 11130731 |
Sulfonylureas and related compounds and use of same |
Luke O'Neill, Rebecca Coll, Avril Robertson, Kate Schroder |
2021-09-28 |
| 10947271 |
Antibacterial agents |
Mark Arnold Thomas Blaskovich |
2021-03-16 |
| 10538487 |
Sulfonylureas and related compounds and use of same |
Luke O'Neill, Rebecca Coll, Avril Robertson, Kate Schroder |
2020-01-21 |
